Posted on November 15, 2022November 15, 2022 Theralink® Technologies Receives Final Medicare Reimbursement Rate Determination and PTAN Enrollment Golden, Colorado — November 14, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision...
Posted on July 25, 2022July 25, 2022 Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer Golden, Colorado — July 25th, 2022 — Theralink Technologies, Inc. (OTC: THER) (“Theralink” or the “Company”), a precis...
Posted on July 6, 2022 Theralink® Technologies to Host Fireside Chat with Dr. Mick Ruxin on June 22nd at 11:00 a.m. ET Denver, Colorado — June 15, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision medi...
Posted on April 25, 2022 Theralink® Technologies Expands Adoption of its Precision Medicine Technology in the Biopharmaceutical Industry Theralink currently supports preclinical and clinical studies across 18 biopharma clients, including multinational corporations...
Posted on March 28, 2022 Avera Health and Theralink® Technologies Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care Theralink’s RPPA (Reverse Phase Protein Array) Technology to be deployed to support and enhance Genomic insights and may ultima...
Posted on March 21, 2022 Theralink® Technologies Announces New PLA Code and Information Submittal to Medicare Contractors for the Theralink Assay for Advanced Breast Cancer Patients Denver, Colorado — March 21, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision med...
Posted on March 14, 2022 Early Results Show >90% Actionability and >75% Clinical Utility for Theralink® Technologies’ Lab Developed Test for Advanced Breast Cancer Patients Denver, Colorado — March 14, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision onc...
Posted on March 1, 2022March 1, 2022 Theralink® Technologies Announces Change of Ticker Symbol and CUSIP DENVER, February 24, 2022 -- Theralink® Technologies - (OTC: THER) ("Theralink" or the "Company"), announces today that it has...
Posted on November 23, 2021November 23, 2021 Theralink® Technologies Announces an Update on its Securities DENVER, October. 22, 2021 -- Theralink® Technologies - (OTC: OBMP) ("Theralink" or the "Company"), a precision medicine molecu...
Posted on March 29, 2021March 30, 2021 Theralink® Technologies Achieves Major Milestone: California Clinical and Public Health License for its Golden, CO Laboratory DENVER, March. 29, 2021 -- Theralink® Technologies - (OTC: OBMP) ("Theralink" or the "Company"), a precision medicine and mol...